Abstract
Atrial fibrillation (AF) ablation strategy is superior to ADT in patients with an initial history of PAF, but its role in patients with a long history of AF as compared with ADT remains a challenge. We compared ablation strategy with antiarrhythmic drug therapy (ADT) in patients with paroxysmal atrial fibrillation (PAF).
Author
Carlo Pappone, MD, PhD, FACC, Giuseppe Augello, MD, Simone Sala, MD, Filippo Gugliotta, BEng, Gabriele Vicedomini, MD, Simone Gulletta, MD, Gabriele Paglino, MD, Patrizio Mazzone, MD, Nicoleta Sora, MD, Isabelle Greiss, MD, Andreina Santagostino, MD, Laura LiVolsi, MD, Nicola Pappone, MD, Andrea Radinovic, MD, Francesco Manguso, MD, PhD and Vincenzo Santinelli, MD
Citation
Journal of the American College of Cardiology, (48)11: 2340-2347, December 5, 2006.
